Clinical Trial

Ketoanalogues for Muscle Mass Loss in Nephrotic Syndrome

Name: Ketoanalogues for Muscle Mass Loss in Nephrotic Syndrome — clinical trial record (NCT05716880)
Creator: DataLookout
License: https://creativecommons.org/licenses/by/4.0/

Study acronym: FORMA

Recruiting Phase 3

View on ClinicalTrials.gov →

Summary

The goal of this non-commercial clinical trial is to assess efficacy and safety of ketoanalogues of essential amino acids in the prevention of protein-energy wasting in nephrotic syndrome.

Trial Details

NCT Number	NCT05716880
Lead Sponsor	Military Institute od Medicine National Research Institute Collaborators: Medical University of Lodz, Medical University of Warsaw
Conditions	Nephrotic Syndrome
Enrollment	150 participants
Start Date	2023-01-03
Primary Completion	2027-02-28 (estimated)
Study Completion	2027-08-31 (estimated)
Updated on ClinicalTrials.gov	2023-02-08